Cornerstone Capital Management Holdings’s PTC Therapeutics PTCT Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,600	Closed	-$190K	–	1405
2016 Q3	$190K	Sell	13,600 -9,000	-40%	-$73.2K	﹤0.01%	1199
2016 Q2	$159K	Buy	+22,600	New	+$166K	﹤0.01%	1227
2016 Q1	–	Sell	-700	Closed	-$23K	–	1539
2015 Q4	$23K	Sell	700 -1,800	-72%	-$53K	﹤0.01%	1403
2015 Q3	$67K	Sell	2,500 -1,400	-36%	-$59.9K	﹤0.01%	1376
2015 Q2	$188K	Buy	3,900 +700	+22%	+$40.8K	﹤0.01%	1208
2015 Q1	$195K	Buy	3,200 +1,900	+146%	+$116K	﹤0.01%	1186
2014 Q4	$67K	Buy	+1,300	New	+$57.2K	﹤0.01%	1196
2014 Q1	–	Sell	-1,300	Closed	-$22K	–	1383
2013 Q4	$22K	Buy	+1,300	New	+$22.8K	﹤0.01%	1203

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Cornerstone Capital Management Holdings's PTCT Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of PTC Therapeutics (PTCT) in Q4 2016, closing a stake of 13,600 shares — an estimated $190K sold.

Cornerstone Capital Management Holdings first reported a position in PTCT in Q4 2013 and held it in 8 quarters. The position peaked at $195K in Q1 2015. 123 funds tracked by Wall St. Rank hold PTCT as of Q4 2016.

Cornerstone Capital Management Holdings reported no remaining PTC Therapeutics position as of Q4 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 13,600 PTC Therapeutics shares in Q4 2016, an estimated $190K.
Cornerstone Capital Management Holdings first reported a position in PTC Therapeutics in Q4 2013 and held it in 8 quarters.
Cornerstone Capital Management Holdings's PTC Therapeutics position peaked at $195K in Q1 2015.
123 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.